With the analysis among 7,085 patents, we discovered top 433 key players by total patent application. Vertex Pharmaceuticals, Inc., IRM LLC, Novartis AG are dominant in this area. They take 32.63% of the total patent filing.
Massachusetts, United States
Patent: 1,464
CITY OF HAMILTON, Bermuda
Patent: 456
Basel-Stadt, Switzerland
Patent: 392
Colorado, United States
Patent: 273
California, United States
Patent: 207
New York, United States
Patent: 144
New York, United States
Patent: 130
New Jersey, United States
Patent: 97
With the analysis among 139 patents, we discovered top 12 start-ups by total patent application. HepaRegeniX GmbH, iOmx Therapeutics AG, Institut National de la Santé et de la Recherche Médicale are active in this area.
Baden-Württemberg, Germany
Patent: 38
Bayern, Germany
Patent: 22
Shanghai Shi, China
Patent: 12
California, United States
Patent: 9
Bretagne, France
Patent: 5
Sichuan Sheng, China
Patent: 5
Shanghai Shi, China
Patent: 3
With the analysis among related 944 patents applied in the last 5 years. We discover 215 most active companies in this area. The fast-growing Vertex Pharmaceuticals, Inc., HepaRegeniX GmbH, Shenzhen Chipscreen Biosciences Co., Ltd. take 11.65% of patent filing during this period.
Massachusetts, United States
Patent: 42
Baden-Württemberg, Germany
Patent: 38
Guangdong Sheng, China
Patent: 30
Minnesota, United States
Patent: 30
Beijing Shi, China
Patent: 26
Bayern, Germany
Patent: 22
With the analysis among related 944 patents in last 5 years, we discover 129 new entrants. HepaRegeniX GmbH, Nanocopoeia, Inc., iOmx Therapeutics AG are the most active new entrants in this area.
Baden-Württemberg, Germany
Patent: 38
Minnesota, United States
Patent: 30
Bayern, Germany
Patent: 22
Massachusetts, United States
Patent: 13
Sichuan Sheng, China
Patent: 13
Jiangsu Sheng, China
Patent: 13
California, United States
Patent: 11
Baden-Württemberg, Germany
Patent: 10
With the analysis among 578 patents, we discovered top 94 universities and scientific research institutions by total patent application. The Scripps Research Institute, Korea Institute of Science & Technology, Institute Of Cancer Research are dominant in this area. They take 30.45% of the total patent filing.
California, United States
Patent: 96
Shanghai Shi, China
Patent: 23
Colorado, United States
Patent: 13
Guangdong Sheng, China
Patent: 10
Baden-Württemberg, Germany
Patent: 10
Liaoning Sheng, China
Patent: 10
New Jersey, United States
Patent: 8
Tartumaa, Estonia
Patent: 7